Physician

Mohamed M. Aboyoussef, M.D.

According to 2025 Medicare claims, Mohamed Aboyoussef, M.D. (NPI: 1972613057) practices rheumatology in the Palm Bay-Melbourne-Titusville, FL market, with the plurality of this provider's patient population coming from Brevard, FL. This provider's primary affiliated billing organization is AMERICAN ARTHRITIS & RHEUMATOLOGY ASSOCIATES LLC (NPI: 1598205072; TIN: 831053374) and primary practice location at 32780-6610.

Aboyoussef's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 703 traditional Medicare patients, billed 659,971 HCPCS/CPT codes, and received $4,893,690 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,937 prescription claims across 640 beneficiaries totaling $2,136,110 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 116 records totaling $1,723. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $3,000 to $4,893,690. Similarly, Part D prescription costs have moved sharply higher in recent years, from $49,315 to $2,136,110. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	32	58	$3,000
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	42	1,993	$32,530
2020	388	20,603	$330,005
2021	533	52,978	$670,190
2022	678	197,324	$1,987,253
2023	761	446,487	$4,368,620
2024	703	659,971	$4,893,690

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	90	169	$49,315
2016	29	50	$7,880
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	12	16	$315
2020	338	1,483	$527,826
2021	515	2,444	$1,129,483
2022	680	2,991	$1,936,875
2023	707	3,361	$2,718,614
2024	640	2,937	$2,136,110

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	574	1,182	$92
96401	Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle	284	2,635	$52
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	202	232	$13
96372	Injection of drug or substance under skin or into muscle	257	419	$10
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	242	414	$1

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	89	2,512	$641,299
Enbrel Sureclick	Etanercept	74	2,184	$592,423
Xeljanz Xr	Tofacitinib Citrate	45	1,350	$274,447
Rinvoq	Upadacitinib	31	1,110	$264,871
Otezla	Apremilast	13	630	$102,890

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	116	$1,723	Janssen Biotech, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mohamed M. Aboyoussef, M.D.?

Tedicare shows public-source Medicare data for Mohamed M. Aboyoussef, M.D. (NPI 1972613057), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mohamed M. Aboyoussef, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mohamed M. Aboyoussef, M.D.?

Mohamed M. Aboyoussef, M.D. is linked to AMERICAN ARTHRITIS & RHEUMATOLOGY ASSOCIATES LLC (billing NPI 1598205072) in the available physician profile data.

Does Mohamed M. Aboyoussef, M.D. have Open Payments data?

Mohamed M. Aboyoussef, M.D. has 116 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.